RE:Beacon Report on PLI...$10 targetWe will get the Pg results later this fall, but clinical trials to date suggest that this final trial has an excellent chance of success.
If that scenario remains valid, with annual sales of $1 billion US, PLI on this drug alone would be valued at $10.
Thats a triple for us or better than $0.40 per share for those who will hold for the 2-3 months until the final clinical results are released.
So I will hold for 6 bagger from here